ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $52,000 | +36.8% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $38,000 | -100.0% | 300 | -50.0% | 0.00% | 0.0% |
| Q1 2021 | $81,366,000 | +214021.1% | 600 | +100.0% | 0.00% | 0.0% |
| Q4 2020 | $38,000 | +11.8% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $34,000 | +17.2% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $29,000 | +11.5% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $26,000 | +73.3% | 300 | 0.0% | 0.00% | – |
| Q4 2019 | $15,000 | +36.4% | 300 | 0.0% | 0.00% | – |
| Q3 2019 | $11,000 | -8.3% | 300 | 0.0% | 0.00% | – |
| Q2 2019 | $12,000 | -29.4% | 300 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $17,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co IV LLC | 2,803,645 | $84,782,000 | 78.57% |
| Cormorant Asset Management, LP | 400,000 | $12,096,000 | 2.49% |
| Deer VII & Co. Ltd. | 175,075 | $5,294,000 | 2.36% |
| QVT Financial LP | 1,193,258 | $36,084,000 | 1.86% |
| Foresite Capital Management I, LLC | 55,767 | $1,686,000 | 1.62% |
| Perceptive Advisors | 445,000 | $13,457,000 | 1.44% |
| SECTORAL ASSET MANAGEMENT INC | 726,424 | $21,967,000 | 0.92% |
| Iguana Healthcare Management, LLC | 25,000 | $756,000 | 0.40% |
| SPHERA FUNDS MANAGEMENT LTD. | 100,000 | $3,024,000 | 0.37% |
| Eventide Asset Management | 62,100 | $1,878,000 | 0.26% |